Answer
Respreeza is maintenance treatment to slow emphysema progression in adults with documented severe alpha1-proteinase inhibitor deficiency who receive optimal pharmacological and non-pharmacological treatment and have progressive lung disease assessed by a healthcare professional experienced in treating this deficiency.
Sources for this answer
- RespreezaCSL Behring UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 11Document updated
Sources checked